NGF Receptor Regulation of Prostate Growth
NGF 受体对前列腺生长的调节
基本信息
- 批准号:7060530
- 负责人:
- 金额:$ 23.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The neurotrophin receptor, p75 NTR, binds the neurotrophin family (e.g. NGF) of growth factors. The p75 NTR is a member of the tumor necrosis factor receptor superfamily. Specific members of this superfamily, including the p75 NTR, share similar sequence motifs designated "death domains" that signal initiation of apoptotic function and inhibition of growth. The p75 NTR exhibits an inverse association of protein expression with malignant progression of the human prostate. Furthermore, we have shown that the p75 NTR is a novel tumor suppressor in human prostate cancer. This is significant since the pathologic elimination of the p75 NTR tumor suppressor facilitates growth during malignant progression of the human prostate. To further elucidate the role of the p75 NTR as a tumor suppressor in the prostate we will test the hypothesis that a functional p75 NTR in prostate cancer cells modifies post-receptor effectors that regains inhibition of growth control. The mechanisms of action of p75 NTR mediated suppression of prostate growth will be assessed in the following five specific aims. In aim 1, we will examine p75 NTR mediated death receptor signal transduction via both the NF-kappaB/I-kappaB pathway and/or activation of the JNK pathway as it relates to inhibition of proliferation and activation of apoptosis. In aim 2, we will demonstrate p75 NTR dependent inhibition of prostate tumor cell growth via impeded progression of the cell cycle and changes in expression/activity of the cyclin/cdk holoenzyme complexes. In aim 3, we will examine p75 wrR mediated induction of apoptosis as it relates to changes in the expression ofpro-apoptotic (e.g. Bax) and anti-apoptotic (e.g. Bcl-xL) effectors, and activation of the downstream caspase cascade. In aim 4 we will examine the dual role of p75 NTR as a metastasis suppressor and establish a mechanistic relationship between p75 NTR dependent suppression of metastasis and induction of apoptosis and/or reduced cell proliferation in the metastatic prostate tumor cells. In aim 5, we will demonstrate pre-clinical gene therapy application of p75 NTR vectors by intra-tumoral injection in SCID mice. These studies should elucidate the mechanism(s) of action of the p75 NTR as a tumor and metastasis suppressor of human prostate growth, and its potential application for gene therapy of prostate cancer.
描述(由申请人提供):神经营养因子受体p75 NTR结合生长因子的神经营养因子家族(如NGF)。p75 NTR是肿瘤坏死因子受体超家族的一员。该超家族的特定成员,包括p75 NTR,具有类似的序列基序,称为“死亡结构域”,该结构域指示凋亡功能的启动和生长的抑制。p75 NTR蛋白表达与人类前列腺恶性进展呈负相关。此外,我们已经证明p75 NTR在人类前列腺癌中是一种新的肿瘤抑制因子。这是重要的,因为p75 NTR肿瘤抑制因子的病理消除促进了人类前列腺恶性进展过程中的生长。为了进一步阐明p75 NTR作为前列腺肿瘤抑制因子的作用,我们将验证前列腺癌细胞中功能性p75 NTR修饰受体后效应物从而恢复生长控制抑制的假设。p75 NTR介导的前列腺生长抑制的作用机制将在以下五个具体目标中进行评估。在目标1中,我们将通过NF-kappaB/I-kappaB途径和/或JNK途径的激活来研究p75 NTR介导的死亡受体信号转导,因为它与抑制增殖和激活凋亡有关。在目标2中,我们将通过阻碍细胞周期的进展和改变细胞周期蛋白/cdk全酶复合物的表达/活性来证明p75 NTR依赖性前列腺肿瘤细胞生长的抑制作用。在目标3中,我们将研究p75 wrR介导的凋亡诱导,因为它与促凋亡(如Bax)和抗凋亡(如Bcl-xL)效应物的表达变化以及下游caspase级联的激活有关。在目标4中,我们将研究p75 NTR作为转移抑制因子的双重作用,并在转移性前列腺肿瘤细胞中建立p75 NTR依赖的转移抑制与诱导凋亡和/或减少细胞增殖之间的机制关系。在目标5中,我们将展示p75 NTR载体在SCID小鼠肿瘤内注射的临床前基因治疗应用。这些研究将阐明p75 NTR作为人类前列腺肿瘤和转移抑制因子的作用机制,以及其在前列腺癌基因治疗中的潜在应用。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells.
p38 MAPK 途径介导前列腺癌细胞中芳基丙酸诱导的 p75 NTR 信使 RNA 稳定性。
- DOI:10.1158/0008-5472.can-07-1792
- 发表时间:2007
- 期刊:
- 影响因子:11.2
- 作者:Quann,EmilyJ;Khwaja,Fatima;Djakiew,Daniel
- 通讯作者:Djakiew,Daniel
Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
- DOI:10.1002/j.1939-4640.2001.tb02199.x
- 发表时间:2001-05
- 期刊:
- 影响因子:0
- 作者:N. Ravindranath;D. Wion;P. Brachet;D. Djakiew
- 通讯作者:N. Ravindranath;D. Wion;P. Brachet;D. Djakiew
Molecular characterization of the loss of p75(NTR) expression in human prostate tumor cells.
人前列腺肿瘤细胞中 p75(NTR) 表达缺失的分子特征。
- DOI:10.1002/mc.1038
- 发表时间:2001
- 期刊:
- 影响因子:4.6
- 作者:Krygier,S;Djakiew,D
- 通讯作者:Djakiew,D
A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.
p75NTR 调节基因表达的 cDNA 微阵列分析揭示了一种新的分化功能。
- DOI:10.1111/j.1432-0436.2005.00040.x
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Nalbandian,Angele;Pang,AlanLY;Rennert,OwenM;Chan,Wai-Yee;Ravindranath,Neelakanta;Djakiew,Daniel
- 通讯作者:Djakiew,Daniel
Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
二氢睾酮 (DHT) 调节 NSAID 诱导前列腺癌细胞凋亡的能力。
- DOI:10.1007/s00280-001-0384-4
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Andrews,Peter;Krygier,Scott;Djakiew,Daniel
- 通讯作者:Djakiew,Daniel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Djakiew其他文献
Daniel Djakiew的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Djakiew', 18)}}的其他基金
REGULATION OF NGF EXPRESSION IN PROSTATE CANCER
前列腺癌中 NGF 表达的调节
- 批准号:
2292628 - 财政年份:1996
- 资助金额:
$ 23.49万 - 项目类别:
NERVE GROWTH FACTOR RECEPTORS & HUMAN PROSTATE NEOPLASIA
神经生长因子受体
- 批准号:
2147178 - 财政年份:1993
- 资助金额:
$ 23.49万 - 项目类别:
NERVE GROWTH FACTOR RECEPTORS & HUMAN PROSTATE NEOPLASIA
神经生长因子受体
- 批准号:
3248725 - 财政年份:1993
- 资助金额:
$ 23.49万 - 项目类别:
相似海外基金
Analysis of transmembrane proteins activity in urological cancers using humanized SCID mouse
使用人源化 SCID 小鼠分析泌尿系统癌症中的跨膜蛋白活性
- 批准号:
19K09674 - 财政年份:2019
- 资助金额:
$ 23.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Core B - SCID Mouse : Human Xenograft Core (Jordan Pober, MD/PhDP.I.)
核心 B - SCID 小鼠:人类异种移植核心(Jordan Pober,医学博士/博士)
- 批准号:
6756347 - 财政年份:2004
- 资助金额:
$ 23.49万 - 项目类别:
EXPERIMENTAL ANALYSIS OF VASCULER CHANGES IN CHRONIC ALLOGRAFT REJECTION USING HUMANIZED SCID MOUSE MODEL.
使用人源化 SCID 小鼠模型对慢性同种异体移植排斥中的血管变化进行实验分析。
- 批准号:
14571526 - 财政年份:2002
- 资助金额:
$ 23.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The heat shock protein(HSP) was investigated as the pathogenesis of focal infection with tonsil by the SCID mouse model
通过SCID小鼠模型研究热休克蛋白(HSP)作为扁桃体局灶性感染的发病机制
- 批准号:
14571629 - 财政年份:2002
- 资助金额:
$ 23.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
通过原位植入手术切除的肺癌组织的原代培养细胞建立类患者 SCID 小鼠模型。
- 批准号:
14571269 - 财政年份:2002
- 资助金额:
$ 23.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)